Advanced Technologies - Breakthrough Medications
9 Deer Park DriveSuite KMonmouth Jct, NJ 08852ph: 908-783-0338fax: 866-482-7417db@cenoxsys.com
Anti-SOD1 Agents
Cenoxsys developed the first anti-SOD compound, pyrimethamine and demonstrated its efficacy in humans in a phase 1 clinical trial. A newer class of compounds with higher potency and greatly reduced side effects is in development in 2016 and will soon be in clinical trials. These compounds will also be developed for certain types of cancer with a a collaborating company.